Skip to main content
Premium Trial:

Request an Annual Quote

Aveo Pharmaceuticals Licenses GeneGo's MetaCore Suite 4.5

NEW YORK (GenomeWeb News) — GeneGo said yesterday that Aveo Pharmaceuticals has licensed its MetaCore 4.5 data-mining suite.
 
The latest version of the suite has disease enrichment and functional ontology functions, and is used to help target, select, and validate biomarkers.
 
The suite, which can concurrently visualize gene expression, proteomics, genetic, and metabolic data, has a management system that can be used to upload and handle thousands of genome-wide files, the company said.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.